Angotzi, F.; Visentin, A.; Scarmozzino, F.; Cellini, A.; Bertorelle, R.; Pizzi, M.; Binotto, G.; Dei Tos, A.P.; Trentin, L.
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases. Curr. Oncol. 2022, 29, 1455-1460.
https://doi.org/10.3390/curroncol29030122
AMA Style
Angotzi F, Visentin A, Scarmozzino F, Cellini A, Bertorelle R, Pizzi M, Binotto G, Dei Tos AP, Trentin L.
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases. Current Oncology. 2022; 29(3):1455-1460.
https://doi.org/10.3390/curroncol29030122
Chicago/Turabian Style
Angotzi, Francesco, Andrea Visentin, Federico Scarmozzino, Alessandro Cellini, Roberta Bertorelle, Marco Pizzi, Gianni Binotto, Angelo Paolo Dei Tos, and Livio Trentin.
2022. "Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases" Current Oncology 29, no. 3: 1455-1460.
https://doi.org/10.3390/curroncol29030122
APA Style
Angotzi, F., Visentin, A., Scarmozzino, F., Cellini, A., Bertorelle, R., Pizzi, M., Binotto, G., Dei Tos, A. P., & Trentin, L.
(2022). Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases. Current Oncology, 29(3), 1455-1460.
https://doi.org/10.3390/curroncol29030122